Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063191 · ClinicalTrials.gov registry record
Activation Timing and Atrial Fibrillation
A clinical trial, sponsored by Essentia Health.
- Terminated
- Registry status
- 3
- Enrollment target
NCT02063191: Clinical Trial study, sponsored by Essentia Health.
NCT02063191 is a clinical trial that was terminated before completion, run by Essentia Health. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02063191 was terminated before completion, sponsored by Essentia Health.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a single center, non-randomized, unblinded study of patients who are followed at Essentia Health - St. Mary's Medical Center and who are referred for a clinically indicated diagnostic electrophysiology (EP) study with or without ablation. During the procedure, events of atrial fibrillation, sinus rhythm and bundle branch block that may occur during the course of the case will be saved electronically and analyzed offline. The stored data will be evaluated off-line for changes in activation timing of the near and far field ventricular signals of the stored events. This proof-of-concept study will attempt to assess whether atrial fibrillation, or bundle branch block can change activation timing compared to baseline sinus rhythm. If no significant activation change is seen, then this finding can be used as a basis to distinguish ventricular tachycardia from atrial fibrillation in future rhythm discrimination methods.
Primary Outcome
Measurement of activation change in near- and far-field ventricular signal between sinus rhythm and atrial fibrillation and/or bundle branch block.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-11 |
Why NCT02063191 stopped before completion
NCT02063191 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02063191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02063191 about?
NCT02063191 is a clinical study titled "Activation Timing and Atrial Fibrillation". This is a single center, non-randomized, unblinded study of patients who are followed at Essentia Health - St. Mary's Medical Center and who are referred for a clinically indicated diagnostic electrophysiology (EP) study with or without ablation. During the procedure, events of atrial fibrillation, ...
What is the current status of trial NCT02063191?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2014-01. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT02063191?
This trial is sponsored by Essentia Health, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia